Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: BioNTech SE

Market Cap 19.65B 22.64B 18.11B 16.97B 31.71B 2,168B 32.37B 216B 83.65B 1,045B 85B 83.17B 3,634B P/E Ratio 2026 *
-17.7x
P/E Ratio 2027 * -17.3x
Enterprise Value 8.81B 10.15B 8.12B 7.61B 14.21B 972B 14.51B 96.85B 37.5B 468B 38.1B 37.28B 1,629B EV / Sales 2026 *
4.11x
EV / Sales 2027 * 4.61x
Free-Float
96.06%
Yield 2026 *
-
Yield 2027 * -
1 day+3.93%
1 week-0.06%
Current month-6.68%
1 month-4.07%
3 months-1.43%
6 months-6.73%
Current year-5.95%
1 week 84.96
Extreme 84.955
90.01
1 month 84.96
Extreme 84.955
97.44
Current year 79.52
Extreme 79.52
124
1 year 79.52
Extreme 79.52
124
3 years 76.53
Extreme 76.5301
131.49
5 years 76.53
Extreme 76.5301
464
10 years 12.52
Extreme 12.525
464
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer 59 2017-12-31
Chief Executive Officer 60 2008-06-01
Director of Finance/CFO - 2025-06-30
Director TitleAgeSince
Chairman 55 2008-06-01
Director/Board Member 69 2008-06-01
Director/Board Member 65 2017-12-31
Date Insider Type Main position Quantity % Market Cap.
05-11Free

Executive/Senior Manager

22,655 0.0094%
05-11Free

Chief Operating Officer

22,655 0.0094%
05-11Free

Chief Financial Officer

33,982 0.0141%
Change 5-day change 1-year change 3-year change Capi.($)
+3.93%-0.06%-15.10%-18.04% 22.64B
+0.72%+1.91%+54.33%+110.97% 55.58B
+0.03%+0.33%+49.22%+43.94% 43.47B
+5.27%-7.82%-1.29%+388.48% 20.96B
+3.81%-5.07%+12.00%-29.52% 15.79B
+0.31%+0.50%+9.10%-40.04% 15.3B
+1.75%+1.92%+29.13%+178.65% 13.45B
+5.27%+5.54%+14.25% - 11.74B
-5.27%-0.43%+87.77%+208.02% 10.96B
+0.63%-3.76%+61.13%+78.62% 10.93B
Average +1.64%-0.76%+30.06%+102.34% 22.08B
Weighted average by Cap. +1.52%+0.54%+33.10%+96.98%

Financials

2026 *2027 *
Net sales 2.14B 2.47B 1.97B 1.85B 3.45B 236B 3.53B 23.54B 9.11B 114B 9.26B 9.06B 396B 2.2B 2.53B 2.03B 1.9B 3.55B 242B 3.62B 24.16B 9.35B 117B 9.5B 9.3B 406B
Net income -1.05B -1.21B -967M -906M -1.69B -116B -1.73B -11.53B -4.46B -55.78B -4.54B -4.44B -194B -1.17B -1.35B -1.08B -1.01B -1.89B -130B -1.93B -12.91B -5B -62.44B -5.08B -4.97B -217B
Net Debt -10.84B -12.49B -9.99B -9.36B -17.5B -1,196B -17.86B -119B -46.15B -577B -46.9B -45.89B -2,005B -9.52B -10.97B -8.78B -8.22B -15.37B -1,051B -15.69B -105B -40.54B -506B -41.19B -40.31B -1,761B
Logo BioNTech SE
BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. The Company is providing technologies including mRNA-based therapies, cell therapies, small molecules and antibodies, which can be utilized for specific purposes or can be even combined with each other in a synergistic manner. It also develops a broad product pipeline using different scientific approaches and technology platforms, including individualized mRNA-based product candidates, chimeric antigen receptor T-cells, checkpoint immunomodulators, targeted cancer antibodies and small molecules. In addition, the Company offers diagnostic products and drug discovery services for other therapeutic areas, including infectious diseases, allergies and autoimmune disorders.
Employees
7,807
Date Price Change Volume
26-06-11 89.54 $ +3.93% 3,095,021
26-06-10 86.15 $ -0.40% 1,213,894
26-06-09 86.50 $ +1.17% 1,173,252
26-06-08 85.50 $ -2.93% 1,121,557
26-06-05 88.08 $ -1.69% 837,442
Trader
Investor
-
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
19
Last Close Price
77.70EUR
Average target price
106.48EUR
Spread / Average Target
+37.03%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BNTX Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!